OBJECTIVE: Evaluate the risk of preterm birth (PTB, <37 weeks) among women with an emergency department (ED) visit or hospitalization for a urinary tract infection (UTI) by trimester of pregnancy. STUDY DESIGN: The sample was selected from liveborn singletons in California born between 2007 and 2012. UTIs were identified from ICD-9 codes in ED or hospital discharge records. Women were classified as having a single UTI if they only had one ED visit or hospitalization. Women with multiple visits during a trimester were considered to have a persistent UTI and women with single visits over more than one trimester were classified as having recurrent UTIs. Risk of PTB, by subtype, was evaluated by trimester of pregnancy and by type of visit (ED or hospital admission) using logistic regression. Women without an ED or hospital visit for a UTI during pregnancy or the month before pregnancy served as the referent population. Risks were adjusted for maternal characteristics and obstetric factors. RESULTS: 2,892,756 women were included, of whom 140,910 (4.9 %) had a diagnosis of a UTI related to an ER visit or hospitalization during pregnancy. Women with a single UTI were at an elevated risk of PTB regardless of the trimester of infection (adjusted relative risks (aRRs) 1.3 for all). While 6.7% of women without a UTI by ER visit or hospitalization had a PTB, 12.3% of women with a persistent UTI delivered preterm (aRR 1.4, 95% confidence interval (CI) 1.3-1.5). (Table) . Of the 8,622 women hospitalized with a single UTI in the second trimester, 3.1% had a spontaneous birth <32 weeks versus 0.7% in the referent population (aRR 3.1, 95% CI 2.7-3.5) and 14.7% overall were preterm (aRR 1.7, 95% CI 1.7-1.8)( Figure) . CONCLUSION: UTIs increase a woman's risk of a PTB, particularly a spontaneous PTB. This risk is elevated regardless of the trimester of pregnancy. Women hospitalized with a UTI during their second trimester are at greatest risk, suggesting that more severe infections further elevate the risk during this time period. Streptococcus (S. agalactiae) in the perinatal period OBJECTIVE: It is fundamentally challenging to predict which bacteria will cause disease or function as harmless commensal organisms. One example is Group B Streptococcus (GBS), which fewer than 0.4/ 1000 will cause invasive early sepsis in neonates. A commensal in adults, GBS colonization of the vagina or rectum occurs in an estimated 10-30% of pregnant women. Given that thousands of women will be exposed to antibiotics to prevent a single case of newborn GBS sepsis, we aimed to determine if the co-occurrence of GBS with other species of the vaginal microbiome could help explain the disparity between maternal prevalence (10-30%) and early invasive newborn disease (<0.02% at baseline, currently <0.004%). STUDY DESIGN: Whole genome shotgun sequencing was performed on vaginal samples (n¼201) collected from 60 gravidae during 3rd trimester, delivery, and 4-6 weeks postpartum. All subjects underwent culture-based GBS screening at 36 weeks. Metagenomic classification was performed using MetaPhlAn2 and Centrifuge. BWA was used to map sequence reads to the GBS reference genome 2603V/R. RESULTS: Metagenomics identified GBS in 4/5 and 50/55 subjects with a positive or negative clinical culture, respectively. There was no significant difference in the relative abundance of GBS based on clinical culture status (p>0.05). On average, GBS-classified samples had a two-fold increased genomic coverage compared to samples classified without (Fig.1A) . Markov chain modeling of GBS status demonstrated that GBS positive subjects are likely to remain positive at subsequent timepoints (Fig.1B) . Probabilistic modeling to examine species co-occurrence revealed numerous significant associations (Fig.1C) . A majority represented positive co-occurrences, including with L. iners. Interestingly, a negative co-occurrence was identified with L. crispatus, including at delivery (Fig.1D) .
CONCLUSION: Our findings are of marked significance as they demonstrate that GBS is a more common commensal in the vagina than previously estimated. We further establish via Markov modeling a high probability of becoming/staying GBS positive and that keystone vaginal species negatively co-occur with GBS, including with L.crispatus, which has a known protective role in vaginal health. Although we had no cases of neonatal GBS disease in our cohort, future studies leveraging our novel observations may have implications for risk modification or tailoring of indications for GBS prophylaxis in labor.
655 Tenofovir to prevent mother-to-child transmission of hepatitis B virus: systematic review with meta-analysis OBJECTIVE: Tenofovir disoproxil fumarate (TDF) has been shown to reduce mother-to-infant hepatitis B virus (HBV) transmission in some studies. We conducted a systematic review and meta-analysis on the efficacy of tenofovir to prevent mother to child transmission of hepatitis B virus. STUDY DESIGN: Medline, Scopus, ClinicalTrials.gov, Embase, and the Cochrane Library at the CENTRAL Register of Controlled Trials
